- Type / Class
- Equity / Common Stock
- Shares outstanding
- 46,498,422
- Total 13F shares
- 55,851,715
- Share change
- +4,675,932
- Total reported value
- $4,621,294,419
- Put/Call ratio
- 13%
- Price per share
- $82.73
- Number of holders
- 315
- Value change
- +$385,980,667
- Number of buys
- 166
- Number of sells
- 137
Quarterly Holders Quick Answers
What is CUSIP 405024100?
CUSIP 405024100 identifies HAE - HAEMONETICS CORP - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 405024100:
Top shareholders of HAE - HAEMONETICS CORP - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Capital Research Global Investors |
13F
|
Company |
14%
|
6,674,751
|
$569,689,998 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
13%
|
5,984,381
|
$510,766,917 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
12%
|
5,397,330
|
$460,662,116 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
9.2%
|
4,270,864
|
$364,518,243 | — | 31 Mar 2024 | |
| Neuberger Berman Group LLC |
13F
|
Company |
8.1%
|
3,788,123
|
$323,281,325 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
3.9%
|
1,832,170
|
$156,375,710 | — | 31 Mar 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
3%
|
1,393,643
|
$118,947,402 | — | 31 Mar 2024 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
2.7%
|
1,266,614
|
$108,105,505 | — | 31 Mar 2024 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
2.6%
|
1,218,211
|
$103,975,000 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
1,125,416
|
$96,068,447 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2%
|
921,070
|
$78,613,325 | — | 31 Mar 2024 | |
| Boston Trust Walden Corp |
13F
|
Company |
1.5%
|
711,865
|
$60,757,677 | — | 31 Mar 2024 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
1.5%
|
699,861
|
$59,733,136 | — | 31 Mar 2024 | |
| Fisher Asset Management, LLC |
13F
|
Company |
1.5%
|
698,040
|
$59,577,712 | — | 31 Mar 2024 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
1.4%
|
628,019
|
$53,601,422 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.2%
|
575,410
|
$49,111,244 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.2%
|
562,454
|
$48,006,000 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1.2%
|
546,785
|
$46,668,100 | — | 31 Mar 2024 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
1.1%
|
502,993
|
$42,930,452 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1%
|
487,226
|
$41,584,733 | — | 31 Mar 2024 | |
| NORGES BANK |
13F
|
Company |
1%
|
473,154
|
$40,383,694 | — | 31 Mar 2024 | |
| SILVERCREST ASSET MANAGEMENT GROUP LLC |
13F
|
Company |
0.98%
|
453,494
|
$38,705,713 | — | 31 Mar 2024 | |
| Boston Partners |
13F
|
Company |
0.96%
|
444,180
|
$38,298,818 | — | 31 Mar 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.87%
|
405,797
|
$34,635,000 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.7%
|
325,998
|
$27,823,929 | — | 31 Mar 2024 | |
| Aristotle Capital Boston, LLC |
13F
|
Company |
0.69%
|
321,526
|
$27,442,207 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.67%
|
312,878
|
$26,704,138 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.62%
|
288,092
|
$24,588,652 | — | 31 Mar 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.59%
|
272,500
|
$23,258,473 | — | 31 Mar 2024 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
0.56%
|
261,673
|
$22,187,253 | — | 31 Mar 2024 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.51%
|
238,101
|
$20,321,920 | — | 31 Mar 2024 | |
| HEARTLAND ADVISORS INC |
13F
|
Company |
0.47%
|
219,065
|
$18,697,198 | — | 31 Mar 2024 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.46%
|
211,677
|
$18,066,632 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0.42%
|
196,329
|
$16,756,680 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.42%
|
193,565
|
$16,520,773 | — | 31 Mar 2024 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.41%
|
190,127
|
$16,227,340 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.39%
|
179,867
|
$15,351,649 | — | 31 Mar 2024 | |
| Retirement Systems of Alabama |
13F
|
Company |
0.39%
|
179,175
|
$15,292,586 | — | 31 Mar 2024 | |
| LONDON CO OF VIRGINIA |
13F
|
Company |
0.39%
|
179,091
|
$15,285,400 | — | 31 Mar 2024 | |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ |
13F
|
Company |
0.38%
|
178,761
|
$15,257,251 | — | 31 Mar 2024 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.38%
|
177,294
|
$15,132,043 | — | 31 Mar 2024 | |
| GREAT LAKES ADVISORS, LLC |
13F
|
Company |
0.36%
|
167,550
|
$14,300,392 | — | 31 Mar 2024 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.36%
|
167,497
|
$14,296,000 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.35%
|
161,146
|
$13,753,811 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.35%
|
160,819
|
$13,725,872 | — | 31 Mar 2024 | |
| SCHWARTZ INVESTMENT COUNSEL INC |
13F
|
Company |
0.32%
|
151,000
|
$12,887,850 | — | 31 Mar 2024 | |
| OBERWEIS ASSET MANAGEMENT INC/ |
13F
|
Company |
0.31%
|
143,695
|
$12,264,368 | — | 31 Mar 2024 | |
| PEREGRINE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.29%
|
134,603
|
$11,488,366 | — | 31 Mar 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.28%
|
131,925
|
$11,259,799 | — | 31 Mar 2024 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
0.28%
|
130,437
|
$11,132,798 | — | 31 Mar 2024 |
Institutional Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q2 2024
As of 30 Jun 2024,
HAEMONETICS CORP - Common Stock (HAE) was held by
315 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
55,851,715 shares.
The largest 10 holders included
Capital Research Global Investors, BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, NEUBERGER BERMAN GROUP LLC, STATE STREET CORP, T. Rowe Price Investment Management, Inc., FRANKLIN RESOURCES INC, ROYCE & ASSOCIATES LP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
315
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
296
Q2 2024 holders
315
Holder diff
19
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.